Abstract
Several genetic mutations have been reported to increase susceptibility to chronic pancreatitis. However, their roles in alcoholic chronic pancreatitis are controversial. We investigated the prevalence of SPINK1 N34S and new CFTR Q1352H mutations in alcoholic chronic pancreatitis in Korea. Forty-three patients with alcoholic chronic pancreatitis were enrolled and 35 healthy individuals served as controls. The SPINK1 N34S mutation was detected by the PCR-RFLP technique. The CFTR Q1352H mutation was examined with PCR direct sequencing. Mean age of chronic pancreatitis and control groups was 53.2 and 51.3 years, respectively. A SPINK1 N34S was detected as a heterozygote in one (2.4%) patient with alcoholic chronic pancreatitis and a heterozygote CFTR Q1352H was detected in one other patient. In the control population, neither SPINK1 nor CFTR mutation was detected. This study shows that SPINK1 N34S and CFTR Q1352H mutations are uncommon and do not play an important role in chronic alcoholic pancreatitis in Korea.
Similar content being viewed by others
References
Haber P, Wilson J, Apte M, Korsten M, Pirola R: Individual susceptibility to alcoholic pancreatitis: still an enigma. J Lab Clin Med 125:305–312, 1995
Pitchumoni CS: Pathogenesis of alcohol-induced chronic pancreatitis: facts, perceptions, and misperceptions. Surg Clin North Am 81:379–390, 2001
Schneider A, Whitcomb DC, Singer MV: Animal models in alcoholic pancreatitis—What can we learn? Pancreatology 2:189–203, 2002
Lankisch PG, Lowenfels AB, Maisonneuve P: What is the risk of alcoholic pancreatitis in heavy drinkers? Pancreas 25:411–412, 2002
Durbec JP, Sarles H: Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreaitis and alcohol, protein and lipid consumption. Digestion 18:337–350, 1978
Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14:141–145, 1996
Gorry MC, Gabbaizedeh D, Furey W, Gates LK Jr, Preston RA, Aston CE, Zhang Y, Ulrich C, Ehrlich GD, Whitcomb DC: Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 113:1063–1068, 1997
Ockenga J, Stuhrmann M, Ballmann M, Teich N, Keim V, Dork T, Manns MP: Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol 95:2061–2067, 2000
Creighton J, Lyall R, Wilson DI, Curtis A, Charnley R: Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet 354:42–43, 1999
Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M: Mutations in the gene encoding the serine protease inhibitor Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25:213–216, 2000
Monaghan KG, Jackson CE, KuKuruga DL, Feldman GL: Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis. Am J Med Genet 94:120–124, 2000
Lee WJ, Kim KA, Lee JS, Jeon YB, Jeong JB, Ryu JK, Kim YT, Yoon YB, Kim CY: Cationic trypsinogen gene mutation in patients with chronic idiopathic pancreatitis. Korean J Gastroenterol 43:41–46, 2004
Pfutzer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, Furey WF, Whitcomb DC: SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 119:615–623, 2000
Threadgold J, Greenhalf W, Ellis I, Howes N, Lerch MM, Simon P, Jansen J, Charnley R, Laugier R, Frulloni L, Olah A, Delhaye M, Ihse I, Schaffalitzky de Muckadell OB, Andren-Sandberg A, Imrie CW, Martinek J, Gress TM, Mountford R, Whitcomb D, Neoptolemos JP: The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 50:675–681, 2002
Truninger K, Witt H, Kock J, Kage A, Seifert B, Ammann RW, Blum HE, Becker M: Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis. Am J Gastroenterol 97:1133–1137, 2002
Teich N, Bauer N, Mossner J, Keim V: Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am J Gastroenterol 97:341–346, 2002
Bhatia E, Choudhuri G, Sikora SS, Landt O, Kage A, Becker M, Witt H: Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology 123:1020–1025, 2002
Witt H, Luck W, Becker M, Bohmig M, Kage A, Truninger K, Ammann RW, O'Reilly D, Kingsnorth A, Schulz HU, Halangk W, Kielstein V, Knoefel WT, Teich N, Keim V: Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 285:2716–2717, 2001
Perri F, Piepoli A, Stanziale P, Merla A, Zelante L, Andriulli A: Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis. Eur J Hum Genet 11:687–692, 2003
Schneider A, Pfutzer RH, Barmada MM, Slivka A, Martin J, Whitcomb DC: Limited contribution of the SPINK1 N34S mutation to the risk and severity of alcoholic chronic pancreatitis: a report from the United States. Dig Dis Sci 48:1110–1115, 2003
Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339:645–652, 1998
Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339:653–658, 1998.
Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohn JA: Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 121:1310–1319, 2001
Kimura S, Okabayashi Y, Inushima K, Kochi T, Yutsudo Y, Kasuga M: Polymorphism of cystic fibrosis gene in Japanese patients with chronic pancreatitis. Dig Dis Sci 45:2007–2012, 2000
Lee JH, Choi JH, Namkung W, Hanrahan JW, Chang J, Song SY, Park SW, Kim DS, Yoon JH, Suh Y, Jang IJ, Nam JH, Kim SJ, Cho MO, Lee JE, Kim KH, Lee MG: A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet 12:2321–2332, 2003
Riordan JR, Rommens JM, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245(4922):1066–1073, 1989
Norton ID, Apte MV, Dixson H, Trent RJ, Haber PS, Pirola RC, Wilson JS: Cystic fibrosis genotypes and alcoholic pancreatitis. J Gastroenterol Hepatol 13:496–499, 1998
Haber PS, Norris MD, Apte MV, Rodgers SC, Norton ID, Pirola RC, Roberts-Thomson IC, Wilson JS: Alcoholic pancreatitis and polymorphisms of the variable length polythymidine tract in the cystic fibrosis gene. Alcohol Clin Exp Res 23:509–512, 1999
Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX: Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut 48:70–74, 2001
Gaia E, Salacone P, Gallo M, Promis GG, Brusco A, Bancone C, Carlo A: Germline mutations in CFTR and PSTI genes in chronic pancreatitis patients. Dig Dis Sci 47:2416–2421, 2002
Zielenski J, Tsui LC: Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 29:777–807, 1995
Casals T, Aparisi L, Martinez-Costa C, Gimenez J, Ramos MD, Mora J, Diaz J, Boadas J, Estivill X, Farre A: Different CFTR mutational spectrum in alcoholic and idiopathic chronic pancreatitis? Pancreas 28:374–379, 2004
Drenth JP, te Morsche R, Jansen JB: Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 50:687–692, 2002
Chandak GR, Idris MM, Reddy DN, Mani KR, Bhaskar S, Rao GV, Singh L: Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut 53:723–728, 2004
Teich N, Mossner J, Keim V: Screening for mutations of the cationic trypsinogen gene: are they of relevance in chronic alcoholic pancreatitis? Gut 44:413–416, 1999
O'Reilly DA, Yang BM, Creighton JE, Demaine AG, Kingsnorth AN: Mutations of the cationic trypsinogen gene in hereditary and non-hereditary pancreatitis. Digestion 64:54–60, 2001
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, K.H., Ryu, J.K., Yoon, W.J. et al. Mutation Analysis of SPINK1 and CFTR Gene in Korean Patients with Alcoholic Chronic Pancreatitis. Dig Dis Sci 50, 1852–1856 (2005). https://doi.org/10.1007/s10620-005-2950-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2950-9